Sionna Therapeutics, Inc. Common Stock SION Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$85.57M-13.7% | -$75.27M-6.5% | -$70.68M+6.8% | -$75.84M-14.3% | -$66.32M-7.5% | ||
| $506K-1.0% | $511K-2.9% | $526K-16.0% | $626K-13.8% | $726K-1.0% | ||
| $16.53M+37.0% | $12.07M+29.7% | $9.3M+32.5% | $7.02M+36.3% | $5.16M+39.0% | ||
| -$2.76M-562% | -$417K-130% | $1.38M+245% | -$950K— | —— | ||
| —— | —— | —— | —— | -$618K-157% | ||
| $960K-57.5% | $2.26M+73.4% | $1.3M-35.2% | $2.01M-3.2% | $2.08M-24.8% | ||
| $1.96M-0.1% | $1.96M+0.1% | $1.96M0.0% | $1.96M0.0% | $1.96M-0.1% | ||
| -$2.14M-0.7% | -$2.13M-0.7% | -$2.11M-0.7% | -$2.1M-0.7% | -$2.08M-9.8% | ||
| -$71.85M-8.4% | -$66.3M-7.9% | -$61.45M+3.8% | -$63.91M-14.3% | -$55.9M-5.9% | ||
| $291K-22.8% | $377K+88.5% | $200K+77.0% | $113K0.0% | $113K+319% | ||
| $178.76M-45.0% | $325.03M+12.3% | $289.35M+12.0% | $258.3M+12.1% | $230.51M+26.1% | ||
| $226.31M+9.5% | $206.65M+26.4% | $163.44M+36.6% | $119.61M+38.4% | $86.44M+54.5% | ||
| —— | —— | —— | —— | —— | ||
| $5.85M+60.8% | $3.64M+81.5% | $2.01M+1,828% | $104K-23.5% | $136K-3.5% | ||
| $5.53M-97.3% | $206.02M— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $2.56M-16.3% | $3.05M-12.5% | $3.49M-4.4% | $3.65M+1.8% | $3.59M+19.5% | ||
| $506K-1.0% | $511K-2.9% | $526K-16.0% | $626K-13.8% | $726K-1.0% | ||
| -$2.14M-0.7% | -$2.13M-0.7% | -$2.11M-0.7% | -$2.1M-0.7% | -$2.08M-9.8% | ||
| $960K-57.5% | $2.26M+73.4% | $1.3M-35.2% | $2.01M-3.2% | $2.08M-24.8% | ||
| $1.96M-0.1% | $1.96M+0.1% | $1.96M0.0% | $1.96M0.0% | $1.96M-0.1% | ||
| $226.31M+9.5% | $206.65M+26.4% | $163.44M+36.6% | $119.61M+38.4% | $86.44M+54.5% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | $202.39M— | ||
| —— | —— | —— | —— | $330.37M— | ||
| -$2.14M-0.7% | -$2.13M-0.7% | -$2.11M-0.7% | -$2.1M-0.7% | -$2.08M-9.8% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | $4.27M— | ||
| —— | —— | —— | —— | —— | ||
| -$72.14M-8.2% | -$66.67M-8.1% | -$61.65M+3.7% | -$64.02M-14.3% | -$56.01M-6.1% | ||
| -$72.14M-8.2% | -$66.67M-8.1% | -$61.65M+3.7% | -$64.02M-14.3% | -$56.01M-6.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Sionna Therapeutics, Inc. Common Stock generate?
- Sionna Therapeutics, Inc. Common Stock (SION) generated -$71.8M in operating cash flow over the trailing twelve months.
- What is Sionna Therapeutics, Inc. Common Stock's free cash flow?
- After $291.0K of capital expenditures, Sionna Therapeutics, Inc. Common Stock's free cash flow was -$72.1M over the trailing twelve months, down 28.8% year over year.
- Where does Sionna Therapeutics, Inc. Common Stock's cash flow data come from?
- Every line is extracted from Sionna Therapeutics, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.